By altering the balance between IL-1R1 and its decoy receptor IL-1R2, ADAM17 enhances sensitivity to IL-1, leading to the activation of nuclear factor-kappa B (NF-κB) and promoting a major pro-inflammatory pathway, contributing to the pathogenesis of insulin resistance. This evidence concerns the gene NFKB1 and Insulin resistance.